Biolife Solutions (BLFS) Asset Writedowns and Impairment (2016 - 2023)

Biolife Solutions' (BLFS) quarterly Asset Writedowns and Impairment came in at $1.4 million in Q4 2023, up 102.03% year-on-year from $701390.8 in Q4 2022, and down 82.95% on a QoQ basis from $8.3 million in Q3 2023.

Biolife Solutions (BLFS) Asset Writedowns and Impairment (2016 - 2023) Analysis & Trends

Biolife Solutions (BLFS) has 4 years of Asset Writedowns and Impairment data on file, last reported at $1.4 million in Q4 2023.

  • On a quarterly basis, Asset Writedowns and Impairment rose 102.03% year-over-year to $1.4 million in Q4 2023; TTM through Dec 2024 was $9.7 million, a 116.17% increase from a year earlier, with the FY2023 full-year figure at $9.7 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q4 2023 stood at $1.4 million, down from $8.3 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for BLFS reached as high as $69.9 million in Q2 2022 and fell as low as -$69.9 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 126.54 Bn 121.33 Bn 1.96 Bn
2 Becton Dickinson 44.82 Bn 44.00 Bn 2.15 Bn
3 Alcon 32.93 Bn 31.28 Bn 1.53 Bn
4 Medline 32.92 Bn 30.68 Bn 1.84 Bn
5 Resmed 29.48 Bn 27.82 Bn 890.98 Mn
6 West Pharmaceutical Services 23.40 Bn 22.97 Bn 329.20 Mn
7 Solventum 14.04 Bn 13.48 Bn 1.10 Bn
8 Cooper Companies 13.79 Bn 13.65 Bn 735.40 Mn
9 Align Technology 12.05 Bn 10.99 Bn 736.59 Mn
10 Biolife Solutions 1.45 Bn 1.37 Bn 17.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 1.42 Mn
Dec 31, 2023 1.42 Mn
Sep 30, 2023 8.31 Mn
Sep 30, 2023 8.31 Mn
Dec 31, 2022 -69.90 Mn
Dec 31, 2022 -69.90 Mn
Jun 30, 2022 69.90 Mn
Jun 30, 2022 69.90 Mn
Dec 31, 2017 336.00
Dec 31, 2017 336.00
Sep 30, 2017 67,664.00
Sep 30, 2017 67,664.00
Jun 30, 2016 86,736.00
Jun 30, 2016 86,736.00